TI
TETmedical, Inc.
SEC filingBiotechnology · Fair Haven, NJ
Amount raised$3.5Msold at filing
Total offering$9.8M$6.3M still open
Investors in the raise45count reported to the SEC
FiledJun 24, 2026first sale Jun 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alex TravisExecutive Officer, Director
John ConleyDirector
Roy CohenExecutive Officer
David FischellExecutive Officer, Director
Christine BuntDirector
Executive officers, directors and promoters as listed on the Form D.